2 Small Studies Find a Clue in the Quest to Help Diagnose CTE in the Living

Bleacher Report
Original Story by Bleacher Report
November 19, 2026
2 Small Studies Find a Clue in the Quest to Help Diagnose CTE in the Living

Two small studies suggest a blood biomarker linked to tau protein, already investigated for Alzheimer's, may help indicate advanced chronic traumatic encephalopathy (CTE) in people with repeated head injuries. While the test shows higher tau fragment levels in those with advanced CTE, it did not reliably detect early-stage disease, and findings are preliminary. Researchers caution that much larger studies are needed to confirm any living-diagnosis utility. The work represents a cautious but notable step toward potentially diagnosing CTE in living patients, contingent on further validation.

Dive Deeper:

  • Researchers pursued a blood test designed to track abnormal tau, a protein associated with neurodegeneration, originally developed for Alzheimer's, to see if it could also signal CTE in individuals with repeated brain trauma.

  • In one study at Washington University in St. Louis, autopsy records led to testing blood from 11 individuals classified with CTE; higher levels of the tau fragment eMTBR-tau243 were found compared with healthy controls, particularly in those with advanced CTE.

  • A separate study by Boston University and Banner Health used blood from 21 former football players who donated brains after death; 16 had advanced CTE, 2 earlier-stage, and 3 without the disease; those with advanced CTE showed significantly higher tau biomarkers, though five also had Alzheimer's.

  • Both studies were presented at scientific meetings and published in JAMA, but researchers note the findings are preliminary and require much larger cohorts to determine diagnostic accuracy for living patients.

  • Experts emphasize that abnormal tau appears in multiple brain diseases and that CTE-related tau differs from Alzheimer's-type tau, underscoring the need for further research to clarify specificity and utility for in-life diagnosis.

  • Editorials accompanying the studies acknowledge the potential significance while urging expansive validation to determine whether this biomarker can become a reliable living-diagnosis tool for CTE.

Latest News

Related Stories